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Objectives. Coronary artery ectasia (CAE), an uncommon finding during coronary arteriography, has been associated with
the presence of aneurysm(s) in other parts of the arterial tree including the abdominal aorta. Varicose veins (VV) or
phlebectasias are a common disorder of the superficial leg veins. Correlations between arterial and venous ectasias have not
been established. We sought to examine whether there is an association between CAE and VV.
Methods and results. CAE was diagnosed in 181 patients out of 7510 eligible patients undergoing coronary arteriography
within 33 months. The prevalence of VV was significantly higher among patients with CAE (40%) compared to 200 aged-
matched patients with coronary artery disease but without CAE (17%) and to 201 randomly selected subjects from the
general population (23%). In multivariate analysis, CAE was found to be significantly and independently associated with
VV (RR ¼ 3.42, 95% confidence interval (CI) 2.24–5.59, p , 0.001).
Conclusion. In this study population, VV were more common in patients with CAE than in those without. This association
was valid in both univariate and multivariate analysis, suggesting the possible existence of a generalised defect of the entire
vascular wall.
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Introduction
Epicardial dilatation of the coronary arteries has been
recognised for decades.1 The most widely used term
for this condition is now ‘coronary artery ectasia’
(CAE).2 In early reports many cases of CAE had been
classified as congenital. A portion of acquired CAE has
been associated with trauma or inflammatory and
connective tissue disorders. Current opinion suggests
that the majority of CAE is a variant of coronary
atherosclerosis, regardless of the severity of any
possible accompanying stenotic lesions.3 – 5 However,
the aetiology of CAE has not been established and it is
not known whether it is a primary endothelial defect, a
pure wall defect or a mixture of both. A generalised
deficit of the wall of the entire arterial system has
already been assumed, as associations have been
found between CAE and ectasias or aneurysms in
other parts of the arterial tree including the abdominal
aorta and peripheral arteries.6 – 10 Histopathological
studies in CAE have shown that the destruction of the
medial musculo-elastic elements accompanies the
degenerative process.3,11 – 13
Primary varicose veins (VV) of the lower limbs
represent abnormal localised or diffuse dilatations of
the superficial venous system, mainly of the long and
short saphenous veins and their tributaries. Looking at
the relative histological findings, it may be claimed
that there are some interesting similarities between the
pathology of the varicose vein wall14,15 and that of the
ectatic coronary arterial wall. In particular, the venous
tunica media and its elastic tissue seem to be among
the key elements involved in varicose veins, just as in
CAE. Coexistence of CAE with venous dilatation has
been described, including varicosities of the coronary
venous tree2 and of the leg veins.10 However,
correlations between arterial and venous ectasias
have never been studied. Though arteries and veins
differ substantially in terms of physiology, we sought
systematically to assess the prevalence of VV in
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patients with CAE. Any possible association between
these two entities would suggest a generalized
vascular wall defect.
Materials and Methods
From 01/05/1999 until 31/01/2002, the coronary
angiogram of every new patient undergoing a diag-
nostic or an interventional procedure was reviewed at
the time of catheterisation. If coronary aneurysmal
disease was suspected, calculations by callipers on still
images were immediately performed. CAE was
considered any discrete or fusiform coronary artery
dilatation, with a maximal luminal diameter greater
than 1.5 times the diameter of the adjacent normal
segment. When the first investigator characterised the
case as CAE, another examiner was randomly
recruited and separately repeated calculations of
luminal diameters. The patient was selected for the
study only when both investigators were in agreement
about the classification of CAE. The patient was then
examined clinically by three physicians among inves-
tigators for the presence of primary VV. All three had
to confirm the presence of VV for the subject to be
characterized as having VV. Primary VV in the lower
limbs included any clearly visible, dilated, elongated
or tortuous veins. Small subcutaneous reticular vari-
cosities or intradermal telangiectasias of small venules
(spider veins) were not classified as VV. Patients with a
history of deep vein thrombosis, congenital heart
disease, connective tissue disease, previous coronary
angioplasty or cardiac surgery were excluded. Patients
who had previously undergone surgical or other
treatment for varicose veins classified as having VV.
The severity of any coronary artery stenosis was not
considered in the patient selection process.
During the study period, 11,248 diagnostic cardiac
catheterisations and percutaneous coronary interven-
tions were performed in 9132 consecutive adult
patients at our institution. After the application of
the exclusion criteria, 7510 patients were eligible for
the study. Among them, 181 patients (2.4%) were
diagnosed as having CAE and comprised group 1.
After the 31st of January 2002, 200 aged and sex-
matched patients were selected in a consecutive
manner from catheterised patients and were found
to have significant coronary artery disease (CAD), but
no CAE (group 2). Concurrently, a group of randomly
enrolled ‘healthy’ individuals, aged and sex-matched
with the group 1, was created from relatives of
hospitalised patients in all the wards of our hospital
(group 3, n ¼ 201). In the latter two groups, we
excluded subjects who were unwilling to participate
as well as those with a history of deep vein thrombosis.
Individuals of group 3 were thought to represent the
‘general population’. Patients of group 2 and group 3
were examined for the presence of primary VV in the
same way as group 1.
All study patients were evaluated for demographic
parameters and for classical risk factors for CAD. The
local ethics committee approved the study protocol
and all study participants gave written informed
consent.
Statistical analysis
Data descriptors are the mean and standard deviation.
Pearson’s chi-squared test, t-test and analysis of
variance, where appropriate, were employed to
compare the baseline characteristics of the study
groups. Logistic regression analysis was employed to
detect possible significant associations between a
dichotomous dependent variable (presence of VV)
and a number of independent ones (age, gender,
diabetes mellitus, cigarette smoking, hypercholesterol-
emia, hypertension, heredity for CAD, Body Mass
Index . 27 kg/m2, and the existence of CAE). In
contrast to the other variables, age was modelled as
a continuous variable. Variable selection was termin-
ated when no candidate variables for entry were
significant at P , 0:05; and all those selected for entry
remained significant at P , 0:10: All tests of statistical
significance were two-tailed and were considered to be
significant at a 0.05 level of statistical significance.
Statistical analyses were performed with SPSS statisti-
cal software (version 8.0, SPSS, Chicago, IL, USA).
Results
The baseline characteristics of the study population
are presented in Table 1. Age and gender were
comparable among the three study groups. According
to univariate analysis, cigarette smoking was more
common in catheterised patients (group 1 and group
2) compared to controls (group 3). Diabetes mellitus
was significantly more prevalent in group 2 than in
both group 1 and group 3, while patients of group 1
had similar prevalence of diabetes with group 3.
Seventy-three subjects with CAE (58 males and 15
females), were found to have primary VV (40% of
group 1 patients). Univariate analysis among group 1
patients showed that those with VV were younger had
a lower prevalence of arterial hypertension and a
higher prevalence of family history for CAD than those
without VV (Table 2). The frequency of VV among
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males was 40.8, 14 and 20.3% in group 1, 2 and 3,
respectively, whereas among females was 38.5, 24 and
30.2% within group 1, 2 and 3, respectively ( p ¼ ns).
In univariate analysis, the frequency of VV was
found to be significantly higher among patients with
CAE, compared both to group 2 and group 3 patients.
Conversely, the prevalence of VV in group 2 patients
was not found to be significantly different from that of
the group 3 (Table 3).
In multivariate logistic regression analysis among
patients catheterised for signs and symptoms for CAD
(i.e. group 1 and group 2 patients, n ¼ 381) with age,
gender, diabetes mellitus, cigarette smoking, hyper-
cholesterolemia, hypertension, heredity for CAD, BMI
.27 kg/m2, and the existence of CAE included as
covariates, age, hypertension and CAE were signifi-
cantly and independently associated with the presence
of VV. The respective relative risks and 95% CIs are
presented in Table 4. According to multivariate
analysis, CAE was strongly and significantly related
to VV increasing the likelihood of VV by a factor of 3.42
(Table 4).
Discussion
Coronary aneurysmal disease is found in up to 5%
of autopsies or angiographic examinations and its
origin is still an enigma. Histological examination
has been performed in only a minority of cases3,
11 – 13 typically revealing marked destruction and
reduction of the medial elastic fibres with disrup-
tion of the internal and external elastic laminae,
usually out of proportion to the degree of the
intimal involvement. The intima almost always
presents classic atherosclerotic changes. However,
the primary degenerative mechanisms leading to
aneurysmal formation have not been elucidated.
Immunohistochemical studies of the wall of the
coronary arteries in CAE have been very few, as in
a case of a patient with familial hypercholesterolae-
mia, which revealed increased matrix metalloproteinase
(MMP) activity within the vessel wall.16 Increased
proteolysis and elastolysis by means of MMP over-
production have been consistently reported from
samples of abdominal aortic aneurysms (AAA) and
arterial aneurysms in other parts of the body.17 – 19 This
MMP overflow within the vessel wall produced by
numerous cell populations appears to greatly contrib-
ute to the aortic wall degeneration, which leads to
expansion. The elaboration of inflammatory cytokines
activating proteolysis has been confirmed in AAA.20
There is also evidence for increased vascular smooth
muscle cell (VSMC) apoptosis and resultant decreased
VSMC density in aortic aneurysmal tissue.21,22
Previous reports have already shown an increased
prevalence of CAE in patients with aneurysms in other
locations of the arterial tree.6 – 10,12 These associations
suggest a common pathogenic mechanism for these
conditions.
Table 1. Baseline characteristics of the study population
CAE (group 1) n ¼ 181 CAD-no CAE (group 2) n ¼ 200 Controls (group 3) n ¼ 201 p value
Age (years) 56 SD 10 57 SD 10 57 SD 11 0.956
Male gender (%) 142 (79%) 150 (75%) 138 (69%) 0.085
Hypertension (%) 88 (49%) 85 (43%) 78 (39%) 0.150
Hypercholesterolemia (%) 72 (40%) 74 (37%) 87 (43%) 0.437
Family history of CAD (%) 40 (22%) 37 (19%) 39 (19%) 0.662
Diabetes (%) 27 (15%) 44 (22%) 25 (12%) 0.028
Obesity (%) 63 (35%) 64 (32%) 54 (27%) 0.232
Smoking (%) 107 (59%) 117 (59%) 74 (37%) ,0.001
CAE, coronary artery ectasia; CAD, coronary artery disease.
Table 2. Baseline characteristics of patients with CAE (group 1, n 5 181) in relation to the presence of VV
VV present ðn ¼ 73Þ No VV ðn ¼ 108Þ p value
Age (years) 53 SD 10 59 SD 9 ,0.001
Within males ðn ¼ 142Þ 58 (41%) 84 (59%) 0.788
Within females ðn ¼ 39Þ 15 (39%) 24 (62%) 0.788
Arterial hypertension ðn ¼ 88Þ 42 (48%) 46 (53%) 0.048
Hypercholesterolemia ðn ¼ 72Þ 32 (44%) 40 (56%) 0.359
Heredity for CAD ðn ¼ 40Þ 23 (58%) 17 (43%) 0.012
Diabetes ðn ¼ 27Þ 10 (37%) 17 (63%) 0.705
Obesity ðn ¼ 63Þ 23 (37%) 40 (64%) 0.444
Smoking ðn ¼ 107Þ 39 (36%) 68 (64%) 0.200
CAE, coronary artery ectasia; VV, varicose veins; CAD, coronary artery disease.
Varicose Veins and Coronary Artery Ectasia 521
Eur J Vasc Endovasc Surg Vol 27, May 2004
In contrast with CAE, vein ectasia, termed as
‘phlebectasia’ or ‘varicose veins’ represent a frequent
clinical situation with a widely varying geographical
appearance. In western countries it has been estimated
to be within the range of 10 – 40%.23,24 Studies
performed in our geographical area have indicated a
7–21% prevalence of VV in the general population.25,26
No one theory explaining the origin of varicosis has
been universally accepted. Histological examination of
the varicosities usually shows degeneration, fragmen-
tation and loss of the medial elastic tissue, fragmenta-
tion and reshape of the collagen fibre network,
accumulation of extracellular matrix widely separ-
ating the hypertrophied medial VSMC and thickening
of the intima.14,15,27 – 30 Dysregulated collagen syn-
thesis,31 disturbance of VSMC/extracellular matrix
organisation and progressive remodelling and vari-
ation of the thickness and elastic properties of the vein
wall,32,33 may precede valvular insufficiency. The role
of proteolysis is unclear as not consistency exists about
the level of activation of various MMPs in VV.28,31,33 – 36
Interestingly, cytokine overproduction has been
demonstrated in VV, just like in AAA.37 Also, both
inhibition of programmed cell death38 as well as
enhanced number of apoptotic cells contributing to
changes in the structural integrity and thus possibly
predisposing to varicosis,39 have been reported in VV.
Although histological and immunohistochemical
similarities exist comparing findings in the wall of
aortic aneurysms and of varicose veins, this is
insufficient to support a common pathogenic mechan-
ism. Direct studies in the same patient have not been
reported from specimens simultaneously derived
from tissues of an AAA and coexisting varicosities
nor from AAA and coexisting CAE. But even if such
studies were performed, it appears doubtful whether
they could explain the origins of the condition,
possibly due to the fact that the time course of the
primary events in any structural change within the
wall of every respective vessel remain vague. While
the timing of the clinical presentation usually differs
between VV, CAE and AAA, it is not known when the
initial degenerating process begins, under what
pathophysiological or haemodynamic circumstances,
whether there is a latent period or a certain type of a
endogenous or exogenous triggering stimulus. Con-
sequently, it cannot be established whether the
defective process is expressed at the same time in all
vessels and locations of a given vessel or with the same
potency within the subclinical period. It is also
unknown whether findings that could be observed
when studying the apparently diseased segments are
relevant to the concurrent findings within the macro-
scopically ‘normal’ parts of the vessel, and vice versa.
On the other hand, supposing that there is a relation
between aneurysmal vascular entities, more questions
arise than answers have been provided. Patients with
VV have a familial predisposition, however, no study
has yet shown horizontal inheritance that could be
attributed to a genetic model. Evidence of a familial
tendency to CAE has been lacking so far. In contrast to
previous thoughts that VV are more common in
women, recent epidemiological studies show a slightly
higher frequency of varicose veins in men than
women, similar to the sex ratio for CAE. The ease of
recognition of VV in contrast to CAE, which is often
asymptomatic requiring coronary angiography for
diagnosis, may play a role in the above discrepancies.
It would be interesting to know the prevalence of VV
in patients with AAA, the prevalence of CAE in age-
and sex-matched patients having VV, as well as if the
high proportion (.40%) of VV in CAE patients that we
observed, is also seen in other populations and
different ethnic groups. Some modern theories chal-
lenge the role of atherosclerosis as a sine qua non for
aneurysmal transformation, regarding it as a coinci-
dence41,42 a hypothesis that may apply to the develop-
ment of varicose veins. The role of autoimmunity as
well as of the adventitia as a significant field of
changes has recently been suggested in the case of
AAA40 – 42 while basic research has not yet focused on
adventitia in either CAE and VV.
From the epidemiological viewpoint, we noticed a
low prevalence of diabetes mellitus in patients with
CAE (14.9%) in relation to patients with CAD. This low
frequency of diabetes has previously been reported
Table 3. Univariate comparisons of the prevalence of VV between
the study groups
Presence of VV Absence of VV p value
CAE (group 1) 73 (40%) 108 (60%) ,0.001*
CAD-no CAE (group 2) 33 (17%) 167 (84%) 0.104†
Controls (group 3) 47 (23%) 154 (77%) ,0.001‡
CAE, coronary artery ectasia; CAD, coronary artery disease; VV,
varicose veins.
*p value for univariate comparison of group 1 vs. group 2.
†p value for univariate comparison of group 2 vs. group 3.
‡p value for univariate comparison of group 1 vs. group 3.
Table 4. Multivariate predictors of VV among 381 patients
catheterised for signs and symptoms indicating CAD (i.e. group
1 1 group 2)
RR 95% CI
(lower)
95% CI
(higher)
p value
Age 0.96 0.937 0.985 0.002
Arterial hypertension 1.73 1.07 2.79 0.025
CAE 3.42 2.24 5.59 ,0.001
CAE, coronary artery ectasia; CAD, coronary artery disease; VV,
varicose veins.
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both in patients with AAA43,44 and patients with VV.45
Interestingly, among our diabetic patients with CAE,
those also presenting VV comprised only one third of
this population. Thus, the perception that diabetes
protects against vascular aneurysms seems to be
substantiated by our findings.
Regardless all these considerations, our results
show that a condition with unusual arterial dilatation
may relate to another condition with venous dilata-
tion. It is certain that more data are needed to support
such a view, with the clinical analogy that exists
between arterial aneurysms also expanding to the
venous system. However, our findings may suggest
that an underlying generalised defect of the vessel
wall may be responsible for vascular aneurysms. If
substantiated, this might have significant implications
for patients presenting with any of the above
conditions.
Undoubtedly, the main limitation of this study is
the lack of specific biochemical, histopathological and
genetic data that could possibly strengthen our
conclusions providing a plausible pathogenic mech-
anism supporting our clinical observations. This was a
cross-sectional observational study and was not
designed to elucidate the mechanisms of development
of two complex, heterogeneous and multi-factorial
clinical entities. Much more work will be required to
evaluate our findings in further patient groups. The
method, we used in this study to define and
characterise a patient as having VV may include
some bias favouring the presence of VV in patients
with CAE, while at the same time making the
recognition of VV less likely in the other patient
groups. We believe that this bias had only a minimal
effect on our results. We did not examine our study
patients by means of a duplex ultrasonography so that
clinically undetectable varicosities or undilated super-
ficial veins but with reflux were not encountered.
However, we believe that this evidence might be
counterbalanced by the fact that we followed the same
clinical methodology to all study groups. Patients with
arterial dilation non-fulfilling the criteria for CAE
were excluded, so by analogy, we excluded patients
with minor degrees of CAE. We do not consider that
this approach weakens our finding.
Conclusions
There is a relationship between CAE and VV, as VV are
more common in patients with CAE than those
without. While there are important difficulties in
studying the underlying pathophysiology and bio-
chemical processes implicated in CAE and VV in the
same patient along the time course of these disorders,
an underlying generalised defect of the entire vascular
wall might be responsible for this observation and
merits further study.
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